10x genomics stock price.

Stock analysis for 10X Genomics Inc (TXG:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

10x genomics stock price. Things To Know About 10x genomics stock price.

View pricing; Search; Xenium In Situ. High-performance in situ from the single cell leader. ... View all 10x Genomics products. Research Areas. Oncology. Neuroscience. Immunology. Drug discovery. Infectious disease. Publications. Browse over 6,100 peer-reviewed publications using 10x Genomics products.Feb 15, 2023 · 10x Genomics (TXG) delivered earnings and revenue surprises of 48.28% and 6.50%, respectively, for the quarter ended December 2022. ... The sustainability of the stock's immediate price movement ... Nov 02, 2023. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 60.33. Press Releases. Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Currently, 10X Genomics Inc does not have a price-earnings ratio. 10X Genomics Inc’s trailing 12-month revenue is $568.4 million with a -30.3% net profit margin. Year-over-year quarterly sales growth most recently was 28.1%. ... Overall, 10X Genomics Inc stock has a Value Score of 6, Estimate Revisions Score of 27 and Quality Score of 66.

Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing. 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction ...

Get the latest 10x Genomics Inc. (TXG) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

10x Genomics, Inc. Stock price London Stock Exchange Equities 0A88 US88025U1097 Medical Equipment, Supplies & Distribution Market Closed - London Stock Exchange. Other stock markets. 09:30:02 2023-05-31 am EDT 5 …10 stocks we like better than 10x Genomics When investing geniuses David and Tom Gardner have a stock tip, ... Brian, is that 10x Genomics is one of those stocks that's just priced for perfection ...Read Full Company Summary for TXG here. View 10x Genomics TXG investment & stock information. Get the latest 10x Genomics TXG detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.10x Genomics will host a conference call to discuss the first quarter 2022 financial results, business developments and outlook after market close on Wednesday, May 4, 2022 at 1:30 PM Pacific Time ...

Company Summary. 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in ...

OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study November 6, 2023. 10x Genomics Reports Third Quarter 2023 Financial Results November 2, 2023. 10x Genomics to Present at the Stephens 25th Annual Conference November 1, 2023. Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model ...

Summary of all time highs, changes and price drops for 10x Genomics; Historical stock prices; Current Share Price: US$45.75: 52 Week High: US$63.57: 52 Week LowNEW YORK – 10x Genomics today priced its initial public offering of 10 million shares of its common stock at $39 per share. The Pleasanton, California-based single-cell sequencing firm said that underwriters will have the right to purchase up to an additional 1.5 million shares of its common stock at the IPO price.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...These forward-looking statements include statements regarding 10x Genomics, Inc.'s ("10x Genomics") product launches, performance, configuration, capabilities and adoption.Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing.

PLEASANTON, Calif., Nov. 2, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended ...Jul 27, 2022 · 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. ... Consensus Price Target is the stock price analysts ... One way to measure the value of 10x Genomics is to see what Wall Street analysts think about it. 10x Genomics has an average analyst rating of Buy from 13 analysts. The average price target for ...TXG stock returns are also predicted based on historical data. According to our research, TXG stock is a bad long-term investment. TXG share price has been in a bear cycle for the past year. 10x Genomics, Inc. stock trend is negative.Jul 15, 2022 · Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down.

Serge Saxonov 10x Genomics (TXG) Stock Price Performance 10x Genomics (TXG) Stock Key Data Summary Additional Data Analysts Historical Quotes …

May 14, 2023 · 10x Genomics : Provides high ... 10x Genomics stock fell hard during the biotech crash of 2022, but has been recovering since then. ... And Twist’s price means it can sell to all of them. 10x Genomics stock opened at $34.93 on Monday. The firm's market capitalization is $4 billion, its price-to-earnings ratio is -23.60, and its beta is 1.70.Does the November share price for 10x Genomics, Inc. ( NASDAQ:TXG ) reflect what it's really worth? ... the company appears quite good value at a 50% discount to where the stock price trades ...Baron Discovery Fund (the Fund) reached its 10-year anniversary on September 30, 2023. Since inception, on a cumulative basis, the fund was up 195.3% (Institutional Shares) compared to the Russell 2000 […] Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and ...Transcript : 10x Genomics, Inc. Presents at Stephens Annual Investment Conference | NASH 2023, Nov-14-2023 10:00 AM Nov. 14: CI UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating Nov. 07: MT25 ພ.ພ. 2023 ... ... shares are attractive at current levels." He has a buy rating on TXG stock and raised his price target to 65 from 58. Notably, analysts ...10x Genomics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time TXG stock price. 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently down 8.01% so far this month. During the month of April, 10X Genomics Inc’s stock price has reached a high of $55.54 and a low of $51.16. Over the last year, 10X Genomics Inc has hit prices as high as $82.96 and as low as $23.81. Year to date, 10X …

With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.

10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 13.01% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $40.08 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ...UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.Headquartered in Pleasanton, California, 10x Genomics, Inc. (NASDAQ:TXG) is a science technology company. On November 2, 2022, 10x Genomics, Inc. (NASDAQ:TXG) stock closed at $26.92 per share.Jul 6, 2023 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. Summary of all time highs, changes and price drops for 10x Genomics; Historical stock prices; Current Share Price: US$45.75: 52 Week High: US$63.57: 52 Week Low10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ...However, the company has seen a 1.19% increase in its stock price over the last five trading sessions. Seeking Alpha reported 2023-11-04 that 10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. …User Ratings; User Analyst Directory; Discussions; Smart Picks. Smart Picks Highest potential stocks based on our proprietary screens combining top analyst ratings and automated financial analysisNov 30, 2023 · UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.

Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to …Nov 29, 2023 · 8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price. Dec 22, 2022 · 10x Genomics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... Note that our analysis may not factor in the latest price-sensitive company ... Instagram:https://instagram. shiba inu coin investingnysearca vtv comparewally weitzwhat can you trade on webull Nov 27, 2023 · 10x Genomics Stock Forecast and Price Target. According to two esteemed experts, the average price target for 10x Genomics to reach this year is $60.00, with a potential upside of approximately 40.48%. This prediction is based on a high estimate of $70.00 and a low estimate of $30.00. A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at June 2023, 10x Genomics had cash of US$391m ... inverted yieldsprott etf Stock analysis for 10X Genomics Inc (TXG*:BIVA) including stock price, stock chart, company news, key statistics, fundamentals and company profile.As of March 06, 2023, 4:00 PM CST, 10X Genomics Inc’s stock price was $48.43. 10X Genomics Inc is down 5.04% from its previous closing price of $51.00. During the last market session, 10X Genomics Inc’s stock traded between $48.52 and $51.17. Currently, there are 114.77 million shares of 10X Genomics Inc stock available for purchase. integraloans 1) 10x Genomics, Inc. TXG. Description: 10x Genomics is a biotechnology company focused on developing advanced genomic tools and technologies to enable researchers to gain deeper insights into ...10x Genomics offers a full set of software for analyzing the data produced by its equipment, ... The dramatic fall in stock price since 2021 might force a larger than planned dilution of existing shareholders. Similarly to 10x Genomics, the path to profitability is through most research labs adopting spatial biology routinely in their workflow.